MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
GLMD — Galmed Pharmaceuticals Ltd.
NasdaqGalmed Pharmaceuticals Ltd.
$4.63
+0.81(+21.05%)
- O
- 3.91
- H
- 4.63
- L
- 3.82
- V
- 303.32K
⏱️ End-of-day dataAs of Sep 9, 2026
Chart
About GLMD
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
IndustryCommon Stock
SectorNot available
IPO DateMar 13, 2014
Employees6
Stock ExchangeNasdaq
Ticker SymbolGLMD
Websitehttps://www.galmedpharma.com
Key Financial Statistics
| Market Cap | $4.97M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.41 - $5.45 |
| 52-Week Avg Volume | 1.59M |
| VWAP | $4.12 |
| Transactions | 3,865 |
| Total Recorded Bars | 3,142 days |